Skip to main content
B

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Filings indexed 833 across all filing types
Latest filing 2026-04-20 Interim / Quarterly Rep…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 667.4KB
Interim / Quarterly Report Classification · 1% confidence The document is an 'Appendix 4C' quarterly cash flow report for Bioxyne Limited, which is a standard ASX regulatory filing for entities to report quarterly cash flows. It includes detailed financial tables and management commentary on the quarterly performance. According to the classification rules, this is a comprehensive financial report for a period shorter than a full fiscal year (quarterly) containing substantive financial data, which fits the 'Interim / Quarterly Report' (IR) category. Q3 2026
2026-04-20 English
Application for quotation of securities - BXN 6 pages 18.2KB
Regulatory Filings
2026-04-13 English
Bioxyne Signs Manufacturing Agreement with Aurora Cannabis 4 pages 476.5KB
Regulatory Filings
2026-03-31 English
Manufacturing Agreement Aurora Supplementary Information 3 pages 459.2KB
Regulatory Filings
2026-03-31 English
BXN to Present at NWR Virtual Conference today 9.30AM AEDT 2 pages 305.3KB
Regulatory Filings
2026-03-24 English
Bioxyne - NWR Virtual Healthcare Conference Presentation 12 pages 1.2MB
Regulatory Filings
2026-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.